## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eightyβfive of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twentyβfour patients came to autopsy, which showed MSA
Pain in multiple system atrophy
β Scribed by F. Tison; G. K. Wenning; M. A. Volonte; W. R. Poewe; P. Henry; N. P. Quinn
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 388 KB
- Volume
- 243
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This review provides an update on therapeutic principles and their implications for practical management in multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized clinically by various combinations of dysautonomia, Parkinsonism, or cerebellar ataxia, often associated with
## Abstract Two patients are described with clinical and neuroimaging features consistent with a diagnosis of multiple system atrophy (MSA). The patients are unusual in that facial myokymia became apparent clinically at some stage in their illness. In each patient, the nature and severity of the in
## Abstract Olivopontocerebellar atrophy (OPCA) is widely accepted as part of the neuropathological spectrum of multiple system atrophy (MSA). The distribution of affected sites in the olivopontocerebellar (OPC) system and their interrelationship remain poorly understood due to lack of quantitative
## Abstract Olfactory dysfunction is a characteristic clinical sign in Parkinson's disease (PD); it is also present in multiple system atrophy (MSA). The pathological basis of hyposmia or anosmia in PD is well known: the olfactory bulb (OB) contains numerous Lewy bodies and severe neuronal loss is